UW Today


September 12, 2013

Initial positive results reported on vaccine to treat genital herpes

Scanning electron micrograph of a human T cells. The GEN-003 herpes vaccine candidate is designed to manipulate the immune responses of T cells, among other therapeutic effects.

The vaccine is the first to significantly reduce the frequency of viral shedding — the surfacing of herpes virus on the genitals — and appears to activate T cell immune responses to the virus.

July 10, 2013

Functional genomics lab to predict potential AIDS vaccines efficacy and find protection markers

Michael Katze

Funded by the NIH at $15 million over five years, the lab will be a national resource to evaluate candidate vaccines from studies around the country.

May 7, 2013

Spokane physician participates as patient in breast cancer vaccine trial

Dr/ Alisa Hideg tumor vaccine trial

Dr. Alisa Hideg, who teaches UW medical students, is grateful for the chance to move science forward toward a future with more options for other patients.

September 28, 2012

News Digest: Poplar rates LEED gold, molecular engineering doc airs tomorrow, next flu shot clinic Oct. 15

Poplar residence hall

LEED gold rating for student residence Poplar Hall || Molecular engineering and science documentary airs tomorrow || Next flu shot clinic Oct. 15 at UW Tower